Men and women were excluded from the study if they had:
• A history of life-threatening asthma that required hospitalisation within
six months before study start.
• Chronic obstructive pulmonary disease.
• Infection of the lower respiratory tract within the week before starting
the study.
• Other respiratory diseases such as tuberculosis or lung cancer.
• Any other disease that the study doctor thought would affect the results
of the study.
A total of 437 patients received at least one dose of the study medicine. The table
below shows the gender and age of these patients.
Patients who received at least one dose of the study medicine
Group 1 Group 2 Group 3 Group 4 Group 5
87 patients 88 patients 88 patients 88 patients 86 patients
Gender - Number of patients (percent)
Female 64 (74%) 54 (61%) 59 (67%) 60 (68%) 47 (55%)
Male 23 (26%) 34 (39%) 29 (33%) 28 (32%) 39 (45%)
Age - in years
Range 19 to 76 18 to 86 20 to 83 18 to 79 19 to 75
Average 47 47 48 48 47
For more detailed information about the patients included in this study, see the
scientific results summaries (links to those summaries are provided at the end of this
document).